Machine-learning analysis identifies factors predicting T cell collection efficiency in CAR T-cell therapy for DLBCL patients. Higher blood volume, not higher circulating T-cell numbers, correlates ...
A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...
Blood centers are scaling cell and gene therapies by leveraging decades of expertise in apheresis, logistics, and quality ...
CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...
As CAR T-cell therapy reaches community oncology, practice leaders discuss the challenges of payer hurdles, single case ...
By deploying a "tag and sort" fix using E3 ligases, scientists successfully cleared the protein buildup and restored T-cell ...
“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...
New connectivity captures data at its source, reducing manual burden and enabling broader value across patient care, research and biopharma collaboration FREMONT, Calif., April 21, 2026 ...
Diets and healthy eating habits hold promise for preventing and treating diseases, but far less is known about acute effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results